Ligand validation:5XAF

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5XAF_GOL_D_504	24%	85%	0.281	0.914	0.41	0.34	-	-	2	0	100%	1
5XAF_GOL_C_504	23%	90%	0.209	0.833	0.35	0.25	-	-	0	0	100%	1
5XAF_GOL_C_506	15%	73%	0.31	0.876	0.5	0.56	-	-	1	0	100%	1
5XAF_GOL_A_503	13%	92%	0.352	0.895	0.32	0.23	-	-	0	0	100%	1
5XAF_GOL_A_506	10%	80%	0.231	0.728	0.38	0.47	-	-	0	0	100%	1
5XAF_GOL_A_504	9%	72%	0.283	0.775	0.36	0.71	-	-	0	0	100%	1
5XAF_GOL_B_503	7%	76%	0.419	0.876	0.24	0.69	-	-	2	0	100%	1
5XAF_GOL_C_505	5%	89%	0.386	0.806	0.37	0.27	-	-	0	0	100%	1
5XAF_GOL_C_501	4%	89%	0.455	0.846	0.4	0.23	-	-	0	0	100%	1
5XAF_GOL_D_503	1%	88%	0.501	0.67	0.36	0.31	-	-	2	0	100%	1
5XAF_GOL_B_504	0%	76%	0.538	0.572	0.44	0.5	-	-	0	0	100%	1
5XAF_GOL_B_505	0%	78%	0.855	0.703	0.42	0.48	-	-	5	0	100%	1
5EYP_GOL_F_201	85%	97%	0.108	0.972	0.05	0.27	-	-	0	0	100%	1
5BMV_GOL_A_505	61%	59%	0.131	0.921	0.45	1.09	-	-	0	0	100%	1
9F07_GOL_B_504	58%	97%	0.114	0.892	0.07	0.23	-	-	1	0	100%	1
8WMU_GOL_A_504	51%	47%	0.138	0.89	0.77	1.26	-	1	0	0	100%	0.821
5OSK_GOL_C_503	50%	89%	0.158	0.91	0.36	0.27	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.